Concepedia

Roger L. Papke

RL

Statistics

Publications

141

Citations

7.7K

H-Index

53

Active since

1980

Affiliations

University of Florida(Current)

Florida College

Northeastern University

Virginia Commonwealth University Medical Center

Roger L. Papke is an author at University of Florida specializing in pharmacology, neuropharmacology, and nicotinic receptor pharmacology.

ORCID

Publications per year

1980–2023

141

Publications

141

An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype

Roger L. Papke, Merouane Bencherif, Patrick M. Lippiello · Neuroscience Letters · 1996 · 274 citations

, , +16

Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes

Roger L. Papke, Paul R. Sanberg, R. Douglas Shytle · Journal of Pharmacology and Experimental Therapeutics · 2001 · 267 citations

, , +17

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

Roger L. Papke, Steve Heinemann · Molecular Pharmacology · 1994 · 260 citations

, , +17

Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis

Roger L. Papke, Julia Kay Porter Papke · British Journal of Pharmacology · 2002 · 248 citations · Full text

, , +15

Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

Christopher M. de Fiebre, Éric Meyer, J C Henry et al. · Molecular Pharmacology · 1995 · 196 citations

, , +17

1–5 of 141